Search

Your search keyword '"Bauser-Heaton H"' showing total 3 results
Start Over Author "Bauser-Heaton H" Journal catheterization and cardiovascular interventions official journal of the society for cardiac angiography interventions
3 results on '"Bauser-Heaton H"'

1. Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.

Author

Grines CL, Klein AJ, Bauser-Heaton H, Alkhouli M, Katukuri N, Aggarwal V, Altin SE, Batchelor WB, Blankenship JC, Fakorede F, Hawkins B, Hernandez GA, Ijioma N, Keeshan B, Li J, Ligon RA, Pineda A, Sandoval Y, and Young MN

Subjects
Aged, 80 and over, Ethnicity, Female, Health Status Disparities, Healthcare Disparities, Hispanic or Latino, Humans, Treatment Outcome, United States epidemiology, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital therapy, Transcatheter Aortic Valve Replacement
Abstract

Cardiovascular disease (CVD) remains the leading cause of death in the United States. However, percutaneous interventional cardiovascular therapies are often underutilized in Blacks, Hispanics, and women and may contribute to excess morbidity and mortality in these vulnerable populations. The Society for Cardiovascular Angiography and Interventions (SCAI) is committed to reducing racial, ethnic, and sex-based treatment disparities in interventional cardiology patients. Accordingly, each of the SCAI Clinical Interest Councils (coronary, peripheral, structural, and congenital heart disease [CHD]) participated in the development of this whitepaper addressing disparities in diagnosis, treatment, and outcomes in underserved populations. The councils were charged with summarizing the available data on prevalence, treatment, and outcomes and elucidating potential reasons for any disparities. Given the huge changes in racial and ethnic composition by age in the United States (Figure 1), it was difficult to determine disparities in rates of diagnosis and we expected to find some racial differences in prevalence of disease. For example, since the average age of patients undergoing transcatheter aortic valve replacement (TAVR) is 80 years, one may expect 80% of TAVR patients to be non-Hispanic White. Conversely, only 50% of congenital heart interventions would be expected to be performed in non-Hispanic Whites. Finally, we identified opportunities for SCAI to advance clinical care and equity for our patients, regardless of sex, ethnicity, or race., (© 2021 Wiley Periodicals LLC.)

Published
2021
Full Text
View/download PDF

2. Percutaneous paraspinal access to the azygos vein to create a neo-vena cava.

Author

Sorensen MW, Bauser-Heaton H, and Petit CJ

Subjects
Child, Preschool, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital physiopathology, Humans, Intracranial Hemorrhages diagnostic imaging, Intracranial Hemorrhages etiology, Intracranial Hemorrhages physiopathology, Male, Recovery of Function, Superior Vena Cava Syndrome diagnostic imaging, Superior Vena Cava Syndrome etiology, Superior Vena Cava Syndrome physiopathology, Treatment Outcome, Vena Cava, Superior diagnostic imaging, Vena Cava, Superior physiopathology, Venous Insufficiency diagnostic imaging, Venous Insufficiency etiology, Venous Insufficiency physiopathology, Azygos Vein surgery, Cardiac Surgical Procedures adverse effects, Decompression, Surgical, Heart Defects, Congenital surgery, Intracranial Hemorrhages surgery, Superior Vena Cava Syndrome surgery, Surgically-Created Structures, Vascular Surgical Procedures, Vena Cava, Superior surgery, Venous Insufficiency surgery
Abstract

We present the case of a child with congenital heart disease repaired in infancy with diffuse central venous occlusions resulting in central venous insufficiency, superior vena cava (SVC) syndrome, and intracranial bleeds. He presented to the catheterization laboratory for multiple transcatheter interventions to recanalize central venous channels which were unsuccessful by conventional methods. Therefore, extravascular venous channels were created to decompress his upper body by creation of a neo-SVC and his lower body with a neo-azygos vein to the neo-SVC. The latter procedure required direct percutaneous access from a paraspinal approach in order to obtain continuity with the azygos vein. At latest follow-up the patient is clinically well and asymptomatic., (© 2019 Wiley Periodicals, Inc.)

Published
2020
Full Text
View/download PDF

3. Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborative.

Author

Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, Nicholson GT, Meadows JJ, Depaolo JS, Aggarwal V, McCracken CE, Mossad EB, Wilson EC, and Petit CJ

Subjects
Cardiac Catheterization adverse effects, Ductus Arteriosus, Patent diagnostic imaging, Ductus Arteriosus, Patent physiopathology, Female, Humans, Infant, Newborn, Male, Punctures, Retrospective Studies, Treatment Outcome, Ultrasonography, Interventional, United States, Axillary Artery diagnostic imaging, Cardiac Catheterization instrumentation, Carotid Arteries diagnostic imaging, Catheterization, Peripheral adverse effects, Ductus Arteriosus, Patent therapy, Femoral Artery diagnostic imaging, Palliative Care, Pulmonary Circulation, Stents
Abstract

Background: Carotid artery (CA) and axillary artery (AA) access are increasingly used for transcatheter stenting of the patent ductus arteriosus (PDA), although reports are limited., Methods: The Congenital Catheterization Research Collaborative (CCRC) reviewed multicenter data from infants who underwent PDA stenting via the CA or AA approach from 2008 to 2017, and compared outcomes to those of infants undergoing PDA stenting via the femoral artery (FA) approach. Post-procedure ultrasound (US) imaging was reviewed., Results: Forty-nine infants underwent PDA stenting from the CA (n = 43) or AA (n = 6) approach, compared with 55 infants who underwent PDA stenting from the FA approach. The PDA was the sole pulmonary blood flow (PBF) source in 61% of infants in the CA/AA cohort, compared with 33% of the FA cohort (p < .01). Ductal tortuosity for CA/AA cohort was Type I (straight) in 10 (20%), Type II (one turn) in 17 (35%), and Type III (multiple turns) in 22 (45%) infants and reflected a greater degree of tortuosity when compared to the FA cohort (p < .01). In 17 infants with CA/AA approach, the "flip technique" was used, and was associated with shorter procedure times for highly tortuous PDA (Type III) patients. Rates of procedural complications were similar across access sites. Most common complications were access site injury (thrombus or bleeding) and stent malposition. No complications were specifically related to the "flip technique.", Conclusions: Use of CA and AA approach for PDA stenting was found to be more commonly employed in sole source PBF and highly tortuous PDAs. Procedural modifications such as the "flip technique" may lead to shorter procedure times. CA and AA approaches are associated with a similar burden of procedural or late complications. Post-procedural surveillance of the CA and AA is suggested, given the incidence of vascular findings on US., (© 2019 Wiley Periodicals, Inc.)

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results